Free Trial

Kura Oncology (KURA) SEC Filings & 10K Form

Kura Oncology logo
$6.24 +0.04 (+0.65%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$6.40 +0.16 (+2.58%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kura Oncology SEC Filings

DateFilerForm TypeView
05/19/2025
5:30 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
5:30 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:29 PM
ARMISTICE CAPITAL, LLC (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G/A
05/02/2025
4:16 PM
Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
3:10 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
3:15 PM
Kura Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2025
4:00 PM
Kura Oncology (Filer)
Form ARS
03/24/2025
3:33 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:21 PM
Hasnain Faheem (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:30 PM
ARMISTICE CAPITAL, LLC (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
02/14/2025
3:42 PM
Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:15 PM
Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
7:57 AM
Flynn James E (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:05 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:09 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
01/28/2025
7:54 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:36 PM
Kura Oncology (Subject)
Powl Brian T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM
Burrows Francis (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM
DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:37 PM
Kura Oncology (Subject)
Leoni Mollie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
7:38 PM
Kura Oncology (Issuer)
Powl Brian T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM
Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM
FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:38 PM
Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:39 PM
Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:36 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
6:42 PM
BlackRock, Inc. (Filed by)
Kura Oncology (Subject)
Form SCHEDULE 13G
01/07/2025
4:48 PM
Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:42 PM
Kura Oncology (Issuer)
Leoni Mollie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
4:25 PM
Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
4:32 PM
Burrows Francis (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:35 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
5:55 PM
Kura Oncology (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/20/2024
4:21 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:32 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
Form SC 13G/A
06/07/2024
3:30 PM
Collins Helen Louise (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Parks Diane L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Issuer)
Szela Mary T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kura Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2024
3:06 PM
Kura Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KURA) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners